Ballicules › Drugs › Bethanechol
Pronunciation: be-THAN-e-koel
Mechanism of action: Bethanechol ballicule
Visual mnemonic: Bethanechol mascot“Bath of ‘choline / Urine ‘choline” baby blue theme → muscarinic
What it is Muscarinic agonist resistant to cholinesterase; urinary retention and neurogenic bladder.
Why this one It stimulates detrusor contraction without nicotinic effects.
What limits it Contraindicated in bladder outlet obstruction, where it can cause rupture. Bronchospasm, bradycardia and cramping.
Molecular structure: Bethanechol
FDA-approved for
urinary retention (~1955)
FDA label
Read the full label on DailyMed ↗
FDA dosing Population Start Target Max
Urinary retention / neurogenic bladder Adults 5-10 mg, repeat hourly until response or max 50 mg reached 10-50 mg TID-QID 50 mg per test dose sequence
Renal Undefined
Hepatic Undefined
Minimum effective dose determined by giving 5-10 mg and repeating same amount at hourly intervals until response or 50 mg total
Instructions Give on an empty stomach; taking soon after eating may cause nausea/vomiting Effects may abolished promptly by atropine if needed
Available strengths
Contraindications Hyperthyroidism Peptic ulcer Latent or active bronchial asthma Pronounced bradycardia or hypotension Vasomotor instability Coronary artery disease Epilepsy Parkinsonism Mechanical GI/urinary obstruction, or questionable GI/bladder wall integrity (e.g. recent surgery/anastomosis) Bladder neck obstruction, spastic GI disturbances, acute inflammatory GI lesions, peritonitis Marked vagotonia
Cautions Cholinergic overstimulation: more likely with dose increases and with subcutaneous route Bronchoconstriction/asthmatic attacks Hypotension with reflex tachycardia
Adverse reactions GI: abdominal cramps, colicky pain, nausea, belching, diarrhea, salivation Flushing, sweating, feeling of warmth Headache, malaise Urinary urgency Bronchial constriction, lacrimation, miosis
Pregnancy Undefined
Lactation Undefined
Cost Bethanechol (URECHOLINE)
What pharmacies pay · NADAC 9/30/26
Generic entry 1983
Principal risk Contraindicated in outlet obstruction; bronchospasm
Classes and tags
Clinical profile
Therapeutic safety burden 1 / 4
Overdose danger 1 / 4
Weight-gain liability 0 / 4
Sedation liability 0 / 4
QT / Torsades 0 / 4
Direct muscarinic antagonism 0 / 4
Embryofetal risk 1 / 4
Legacy pregnancy category Unknown / historical label unavailable
Defining liability Generally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
Open Bethanechol in the interactive console ↗
Memory aids: interaction avatars
no kinetic interactions
Open Bethanechol in the interactive console ↗